MYRIAD GENETICS, INC. Share-based Payment Arrangement, Expensed and Capitalized, Amount
MYRIAD GENETICS, INC. (MYGN) reported Share-based Payment Arrangement, Expensed and Capitalized, Amount of $1.70 million for the 12-month period ending 2020-06-30, per its 10-K filed 2020-08-13.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 · last filed 2020-08-13
- MYRIAD GENETICS, INC. share-based payment arrangement, expensed and capitalized, amount for fiscal 2020 was $1.70M, a 70.00% increase from fiscal 2019.
- MYRIAD GENETICS, INC. share-based payment arrangement, expensed and capitalized, amount for fiscal 2019 was $1.00M, a 900.00% increase from fiscal 2018.
- MYRIAD GENETICS, INC. share-based payment arrangement, expensed and capitalized, amount for fiscal 2018 was $100.00K, a 95.65% decline from fiscal 2017.
- MYRIAD GENETICS, INC. share-based payment arrangement, expensed and capitalized, amount for fiscal 2017 was $2.30M, a 21.05% increase from fiscal 2016.
| Period end | Share-based Payment Arrangement, Expensed and Capitalized, Amount 12 month | Share-based Payment Arrangement, Expensed and Capitalized, Amount 12 month as first filed |
|---|---|---|
| 2020-06-30 | $1.70M 10-K · filed 2020-08-13 | |
| 2019-06-30 | $1.00M 10-K · filed 2020-08-13 | |
| 2018-06-30 | $100.00K 10-K · filed 2020-08-13 | |
| 2017-06-30 | $2.30M 10-K · filed 2019-08-13 | |
| 2016-06-30 | $1.90M 10-K · filed 2018-08-24 | |
| 2015-06-30 | $1.80M 10-K · filed 2017-08-09 | |
| 2014-06-30 | $1.30M 10-K · filed 2016-08-10 | $1.32M 10-K · filed 2014-08-13 |
| 2013-06-30 | $900.00K 10-K · filed 2015-08-12 | $885.00K 10-K · filed 2014-08-13 |
| 2012-06-30 | $892.00K 10-K · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |